Zhongtian Xiang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Zhongtian Xiang has a total of 6 co-authors. Here are the top co-authors by number of shared publications:
- Bo Wu
Department of Thoracic Surgery, The Second Affiliated Hospital of Nanchang University, Nanchang, China
1 shared publication Jianhui Chen
Department of Cardiothoracic Surgery, Xiaogan Hospital Affiliated to Wuhan University of Science and Technology, Xiaogan Central Hospital, Xiaogan, China
1 shared publicationJiayi Duan
School of Clinical Medicine, Ningxia Medical University, Yinchuan 750004, China
1 shared publication- Nan Feng
Department of Thoracic Surgery, The Second Affiliated Hospital of Nanchang University, Nanchang, China
1 shared publication - Wenxiong Zhang
Department of Thoracic Surgery, The Second Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, China
1 shared publication Xiang Zhang
Department of Thoracic Surgery, The Second Affiliated Hospital of Nanchang University, Nanchang, China
1 shared publication
Latest Publications
- 28 March 2025
- Published by Elsevier in Journal of Affective Disorders
- Vol. 380, 270-278
The U-shape relationship between the aggregate index of systemic inflammation and depression in American adults: A cross-sectional study
- 28 March 2025
- Published by Elsevier in Journal of Affective Disorders
- Vol. 380, 270-278
The U-shape relationship between the aggregate index of systemic inflammation and depression in American adults: A cross-sectional study
- Open Access
- 27 October 2023
- Published by Wolters Kluwer Health in Medicine
- Vol. 102 (43) , e35619
The influence of different sequences of vessel ligation on long-term survival during video-assisted thoracoscopic lobectomy for non-small cell lung cancer: A matched cohort study
In lobectomy of patients with lung cancer, the principle of operation is to cut off the pulmonary vein first, but it is often not taken seriously in clinical practice. We conducted this research to compare the impact of different sequences of pulmonary vessel ligation on the long-term survival of patients. This cohort study included 1239 patients treated surgically with video-assisted thoracoscopic lobectomy from January 2015 to December 2019 at The Second Affiliated Hospital of Nanchang University. Survival and perioperative indicators were compared between a Vein-first group (VF) and an artery-first group. After matching, 364 patients were included in each group for analysis. VF was associated with better overall survival (hazard ratio: 1.96 [1.4~2.74], P < .0001) and disease-free survival (hazard ratio: 1.65 [1.22~2.24], P = .0011). Meanwhile, the survival advantage of VF was achieved in almost all subgroups, particularly in the pathological tumor node metastasis stage I-II group and squamous cell carcinoma group. We obtained no significant differences in perioperative indications (operation time, hospital stay, etc) between VF and artery-first group. With better overall survival and disease-free survival, especially for pathological stage I-II squamous cell carcinoma, vein-first ligation should be strictly observed in lobectomy for patients with non-small cell lung cancer.
- 27 October 2023
- Published by Wolters Kluwer Health in Medicine
- Vol. 102 (43) , e35619
Open AccessThe influence of different sequences of vessel ligation on long-term survival during video-assisted thoracoscopic lobectomy for non-small cell lung cancer: A matched cohort study
In lobectomy of patients with lung cancer, the principle of operation is to cut off the pulmonary vein first, but it is often not taken seriously in clinical practice. We conducted this research to compare the impact of different sequences of pulmonary vessel ligation on the long-term survival of patients. This cohort study included 1239 patients treated surgically with video-assisted thoracoscopic lobectomy from January 2015 to December 2019 at The Second Affiliated Hospital of Nanchang University. Survival and perioperative indicators were compared between a Vein-first group (VF) and an artery-first group. After matching, 364 patients were included in each group for analysis. VF was associated with better overall survival (hazard ratio: 1.96 [1.4~2.74], P < .0001) and disease-free survival (hazard ratio: 1.65 [1.22~2.24], P = .0011). Meanwhile, the survival advantage of VF was achieved in almost all subgroups, particularly in the pathological tumor node metastasis stage I-II group and squamous cell carcinoma group. We obtained no significant differences in perioperative indications (operation time, hospital stay, etc) between VF and artery-first group. With better overall survival and disease-free survival, especially for pathological stage I-II squamous cell carcinoma, vein-first ligation should be strictly observed in lobectomy for patients with non-small cell lung cancer.